Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

355
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
355
Long-term Depression01:05

Long-term Depression

33.8K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.8K
Long-term Depression01:03

Long-term Depression

3.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.6K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.1K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computational and Experimental Investigations of Mg-Doped SnO<sub>2</sub> Electron Transport Layer for Indoor Perovskite Solar Cells.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Extrahepatic bile duct on MRCP: Does incidentally detected dilation in the absence of signs or symptoms of obstruction require further investigation?

European journal of radiology·2026
Same author

Right-Sided Extravalvular Damage: An Overlooked Driver of Risk Model Failure in Low-Flow, Low-Gradient Aortic Stenosis.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same author

Shifting diversity patterns of non-Apis bees (family Apidae) across disturbance gradients in a Himalayan foothill landscape.

Environmental monitoring and assessment·2025
Same author

Aortic valve calcification alone identifies transcatheter aortic valve replacement benefit in classical low-flow, low-gradient aortic stenosis.

The Journal of invasive cardiology·2025
Same author

Comparative Outcomes of Transcatheter Aortic Valve Replacement and Conservative Management in Patients with Low-Flow, Low-Gradient Aortic Stenosis.

The American journal of cardiology·2025

Related Experiment Video

Updated: Apr 1, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.9K

Recognising and Treating Depression in the Elderly.

Ranbir Singh1, Nadeem Mazi-Kotwal, Madhusudan Deepak Thalitaya

  • 1East London NHS Foundation Trust, London, UK.

Psychiatria Danubina
|September 30, 2015
PubMed
Summary
This summary is machine-generated.

Depression in older adults is common and treatable, though remission may take longer. Early recognition and individualized care are key for better outcomes in elderly depression.

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

704
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.7K

Related Experiment Videos

Last Updated: Apr 1, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.9K
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

704
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.7K

Area of Science:

  • Geriatric Medicine
  • Psychiatry
  • Public Health

Background:

  • Depression significantly impacts healthcare costs and is projected to be a leading cause of disease burden globally.
  • Late-life depression is linked to disability, increased mortality, and adverse outcomes in physical health conditions.
  • Approximately 14% of community-dwelling older adults worldwide exhibit clinically relevant depressive symptoms.

Purpose of the Study:

  • To highlight the importance of recognizing and understanding depression in the elderly within primary care settings.
  • To emphasize that depression is a treatable medical condition, not an inevitable part of aging.

Main Methods:

  • Discusses the challenges in recognizing depression in the elderly, often triggered by co-existing medical illnesses.
  • Highlights that while most patients welcome support, they may exhibit fear or resistance to treatment.
  • Stresses the need for patience, perseverance, and individualized treatment approaches due to unique patient characteristics.

Main Results:

  • The prognosis for recovery from depression is comparable between younger and older adults.
  • Remission of depressive symptoms may require a longer duration in older patients compared to younger individuals.

Conclusions:

  • Depression in older adults is a treatable condition that requires attentive care.
  • Recognizing and addressing depression symptoms in primary care is crucial for improving the health and well-being of the elderly population.